Avoiding Neuromuscular Blockers to Reduce Complications

Clinical trial NCT03962725 · TERMINATED

Trial details

NCT number: NCT03962725
Sponsor: Beth Israel Deaconess Medical Center
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Respiratory Failure Respiratory Infection Aspiration Pneumonia Pneumonitis Atelectasis Bronchospasm

Start date: 2019-08-07
Primary completion: 2022-12-19
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.